On Neurodegenerative Diseases, Models, and Treatment Strategies: Lessons Learned and Lessons Forgotten a Generation Following the Cholinergic Hypothesis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bartus, 1982, The cholinergic hypothesis of geriatric memory dysfunction, Science, 217, 408, 10.1126/science.7046051
Bartus, 1988
Bartus, 1986, Cholinergic treatment for age-related memory disturbances: Dead or barely coming of age?, 421
Fibiger, 1991, Cholinergic mechanisms in learning, memory and dementia: A review of recent evidence, Trends Neurosci., 14, 220, 10.1016/0166-2236(91)90117-D
Sarter M., 1991, Cholinergic controversies, Trends Neurosci., 14, 483
Davis, 1998, Future therapeutic approaches to Alzheimer's disease, J. Clin. Psychiatry, 59, 14
Tariot, 1996, Contemporary treatment approaches to Alzheimer's disease, Consult. Pharm., 11, 16
Wisniewski, 1976, Neuropathology of the aging brain, 265
Roth, M, 1978, Diagnosis of senile dementia and related forms of dementia. In, Alzheimer's Disease: Senile Dementia and Related Disorders, (, R. Katzman, Ed.), p, 25, Raven Press, New York.
Constantinidis, 1978, Is Alzheimer's disease a major form of senile dementia? Clinical, anatomical, and genetic data, 15
Flicker, 1984, Effects of aging and dementia upon recent visuospatial memory, Neurobiol. Aging, 5, 10.1016/0197-4580(84)90003-4
Crook, 1986, Age-associated memory impairment: proposed diagnostic criteria and measure of clinical change, Dev. Neuropsychol., 2, 261, 10.1080/87565648609540348
Bartus, 1995, Aging in the Rhesus monkey: Debilitating effects on short term memory, J. NIH Res., 7, 69
Bartus, 1978, Aging in the Rhesus monkey: Debilitating effects on short-term memory, J. Gerontol., 33, 858, 10.1093/geronj/33.6.858
Bartus, 1979, Psychostimulants of the central nervous system: Effects on short term memory in young vs. aged monkeys, J. Am. Geriatr. Soc., 27, 11, 10.1111/j.1532-5415.1979.tb06042.x
Sathananthan, 1975, Cerebral vasodilators: A review, 155
Lehmann, 1975, Central nervous system stimulants and anabolic substancees in geropsychiatric therapy, 179
Spence, 1960
Watson, 1967
Bartus, 1985, The cholinergic hypothesis: An historical overview, current perspective, and future directions
Drachman, 1974, Human memory and the cholinergic system: A relationship to aging?, Arch. Neurol., 30, 113, 10.1001/archneur.1974.00490320001001
Hollister, 1968
Longo, 1966, Behavioral and electroencephalographic effects of atropine and related compounds, Pharmacol. Rev., 18, 965
Bartus, 1987, Cholinergic psychopharmacology: An integration of human and animal research in memory, 219
Bartus, 1978, Aging in the Rhesus monkey: Specific behavioral impairments and the effects of pharmacological intervention, 225
Bartus, 1979, Physostigmine and memory: Effects in young and aged nonhuman primates, Science, 270, 1087, 10.1126/science.227061
Davis, 1981, Cholinomimetic agents and human memory: Clinical studies in Alzheimer's disease and scopolamine dementia
Smith, 1978, Possible biochemical basis of memory disorder in Alzheimer's disease, Ann. Neurol., 3, 471, 10.1002/ana.410030602
Flicker, 1985, Animal and human memory dysfunctions associated with aging, cholinergic lesions and senile dementia, 515
Flicker, 1992, Hypersensitivity to scopolamine in the elderly, Psychopharmacology (Berlin), 107, 437, 10.1007/BF02245172
Sunderland, 1985, Scopolamine challenges in Alzheimer's disease, Psychopharmacology, 87, 247, 10.1007/BF00431817
Litvan, 1995, What can preservation of autobiographical memory after muscarinic blockade tell us about the scopolamine model of dementia?, Neurology, 45, 387, 10.1212/WNL.45.2.387
Bowen, 1976, Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies, Brain, 99, 459, 10.1093/brain/99.3.459
Davies, 1976, Selective loss of central cholinergic neurons in Alzheimer's disease, Lancet, 2, 1403, 10.1016/S0140-6736(76)91936-X
Perry, 1977, Necropsy evidence of central cholinergic deficits in senile dementia, Lancet, 1, 189, 10.1016/S0140-6736(77)91780-9
Haubrich, 1977, Regulation of acetylcholine synthesis in nervous tissue, Life Sci., 20, 1465, 10.1016/0024-3205(77)90437-4
Jenden, 1976, Regulation of acetylcholine synthesis: Does cytoplasmic acetylcholine control high affinity choline uptake?, Science, 194, 635, 10.1126/science.982031
Arai, 1984, Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia, J. Neurochem., 43, 388, 10.1111/j.1471-4159.1984.tb00913.x
Cross, 1983, Monoamine metabolism in senile dementia of Alzheimer type, J. Neurol. Sci., 60, 383, 10.1016/0022-510X(83)90149-1
Cross, 1981, Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease, Br. Med. J., 282, 93, 10.1136/bmj.282.6258.93
Soininen, 1981, Homovanillic acid and 5-hydroxyindolacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type, Acta Neurol. Scand., 64, 101, 10.1111/j.1600-0404.1981.tb04392.x
Whitehouse, 1981, Alzheimer's disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis, Ann. Neurol., 10, 122, 10.1002/ana.410100203
Whitehouse, 1981, Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain, Science, 215, 1237, 10.1126/science.7058341
Enna, 1980
Lippa, 1980, Brain cholinergic dysfunction and memory in aged rats, Neurobiol. Aging, 1, 13, 10.1016/0197-4580(80)90019-6
Lippa, 1981, Age-related alterations in neurotransmitter receptors: An electrophysiological and biochemical analysis, Neurobiol. Aging, 2, 3, 10.1016/0197-4580(81)90052-X
Gallagher, 1998, Effects of aging on cognition and hippocampal/cortical systems, Soc Neurosci. Abstr., 24
Smith, 1999, Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy, Proc. Natl. Acad. Sci. USA, 96, 10893, 10.1073/pnas.96.19.10893
Davis, 1999, Cholinergic markers in elderly patients with early signs of Alzheimer's disease, JAMA, 281, 1401, 10.1001/jama.281.15.1401
Davis, 1978, Physostigmine: Improvement of long-term memory processes in normal humans, Science, 201, 272, 10.1126/science.351807
Davis, 1979, Enhancement of memory by physostigmine, N. Engl. J. Med., 301, 946, 10.1056/NEJM197910253011721
Davis, 1978, Pharmacological investigations of the cholinergic imbalance hypothesis of movement disorders and psychosis, Biol. Psychiatry, 13, 23
Davis, K., R. Mohs, B. Davis, G. Rosenberg, T. Horvath, and Y. DeNigris. 1981. Cholinomimetic agents in human memory: Preliminary observations in Alzheimer's disease. Cholinergic Mechanisms: Phylogenetic Aspects, Central and Peripheral Synapses, and Clinical Significance (G. Pepeu and H. Ladinsky, Eds.), pp. 929–936. Plenum, New York.
Davis, 1982, Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine, Am. J. Psychiatry, 139, 1421, 10.1176/ajp.139.11.1421
Christie, 1981, Physostigmine and arecoline: Effects of intravenous infusions in Alzheimer's presenile dementia, Br. J. Psychiatry, 138, 46, 10.1192/bjp.138.1.46
Thal, 1986, Acute and chronic effects of oral physostigmine and lecithin in Alzheimer's disease, Prog. Neuropsychopharmacol. Biol. Psychiatr., 10, 617, 10.1016/0278-5846(86)90032-1
Mohs, 1985, Oral physostigmine treatment of patients with Alzheimer's disease, Am. J. Psychiatry, 142, 28, 10.1176/ajp.142.1.28
Stern, 1988, Long-term administration of oral physostigmine in Alzheimer's disease, Neurology, 38, 1837, 10.1212/WNL.38.12.1837
Bartus, 1980, Recent memory deficits in aged Cebus monkeys and facilitation with central cholinimimetics, Neurobiol. Aging, 1, 145, 10.1016/0197-4580(80)90008-1
Bartus, 1983, An evaluation of drugs for improving memory in aged monkeys: Implication for clinical trials in humans, Psychopharmacol. Bull., 19, 168
Summers, 1986, Oral tetrahydroaminoacridine in long-term treatment of senile dementia, N. Engl. J. Med., 315, 1241, 10.1056/NEJM198611133152001
Davis, 1992, A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease, N. Engl. J. Med., 327, 1253, 10.1056/NEJM199210293271801
Bartus, 1988, The need for common perspectives in the development and use of animal models for age-related cognitive neurodegenerative disorders, Neurobiol. Aging, 9, 445, 10.1016/S0197-4580(88)80097-6
Bartus, 1987, Animal models for age-related memory disturbances, 67
Bartus, 1987, On possible relationships between Alzheimer's disease, age-related memory loss and the development of animal models, 129
Bartus, 1986, Commentary on animal models of Alzheimer's and Parkinson's disease, Integr. Psychiatry, 4, 74
Bartus, 1986, Behavioral and biochemical effects of nucleus basalis magnocellularis lesions: Implications and possible relevance to understanding or treating Alzheimer's disease, 345, 10.1016/S0079-6123(08)64315-0
Bartus, R., C. Flicker, and R. Dean. 1983. Logical principles in the development of animal models of age-related memory loss. In Clinical and Preclinical Assessment in Geriatric Psychopharmacology (T. Crook, Ed.), pp. 263–299. Mark Powley Associates, New Caanan, CT.
Bartus, R., and R. Dean. 1985. Developing and utilizing animals models in the search for an efffective treatment for age-related memory disturbances. In Normal Aging, Alzheimer's Disease, and Senile Dementia (C. Gottfries, Ed.), pp. 231–267. Univ. of Brussels Press, Brussels, UK.
Bartus, 1983, Behavioral and pharmacological studies using animal models of aging: Implications for studying and treating dementia of Alzheimer's type, Banbury Rep., 1515, 207
Bartus, 1979, Aging in the Rhesus monkey: Effects on visual discrimination and reversal learning, J. Gerontol., 34, 209, 10.1093/geronj/34.2.209
Bartus, R. 1979. The effects of aging on visual memory, sensory processing and discrimination learning in a nonhuman primate. In Aging: Sensory Systems and Communication in the Elderly (J. Ordy, Ed.), pp. 85–113. Raven Press, New York.
Bartus, 1979, Recent memory in aged nonhuman primates: Hypersensitivity to visual interference during retention, Exp. Aging Res., 5, 385, 10.1080/03610737908257214
Riopelle, A., and C. Rogers. 1965. Age changes in chimpanzees. In Behavior of Nonhuman Primates (A. Schrier, Ed.), pp. 449–462. Academic Press, New York.
Medin, 1973, Age differences in retention of concurrent discrimination problems in monkeys, J. Gerontol., 28, 63, 10.1093/geronj/28.1.63
Arnsten, 1985, Catecholamines and cognitive decline in aged nonhuman primates, 218
Bachevalier, 1991, Aged monkeys exhibit behavioral deficits indicative of widespread cerebral dysfunction, Neurobiol. Aging, 12, 99, 10.1016/0197-4580(91)90048-O
Bachevalier, 1993, Behavioral changes in aged rhesus monkeys, Neurobiol. Aging, 14, 619, 10.1016/0197-4580(93)90048-G
Marriott, 1980, Age differences in short-term memory in test-sophisticated rhesus monkeys, Age, 3, 7, 10.1007/BF02434999
Moss, 1986, Effects of Aging on visual recognition memory in the Rhesus monkey, Primate Rep., 14, 133
Moss, 1988, Effects of aging on visual recognition memory in the rhesus monkey, Neurolbiology of Aging, 9, 495, 10.1016/S0197-4580(88)80103-9
Moss, 1997, Recognition memory span in rhesus monkeys of advanced age, Neurobiol. Aging, 18, 13, 10.1016/S0197-4580(96)00211-4
Presty, 1987, Age differences in recognition memory of the rhesus monkey (Macaca mulatta), Neurobiol. Aging, 8, 435040, 10.1016/0197-4580(87)90038-8
Rapp, 1991, Recognition memory deficits in a subpopulation of aged monkeys resem le the effects of medial temporal lobe damage, Neurolbiol. Aging, 12
Rapp, 1989, Evidence for task-dependent memory sysfunction in the aged monkey, J. Neurosci., 9, 7, 10.1523/JNEUROSCI.09-10-03568.1989
Voytko, 1993, Cognitive changes during normal aging in monkeys assessed with an automated test apparatus, Neurobiol. Aging, 14, 643, 10.1016/0197-4580(93)90055-G
Goldman-Rakic, 1996, The prefrontal landscape: Implications of functional architecture for understanding human mentation and the central executive, Phil. Trans. R. Soc. London, 351, 1445, 10.1098/rstb.1996.0129
Hanninen, 1997, Decline of frontal lobe functions in subjects with age-associated memory impairment, Neurology, 48, 148, 10.1212/WNL.48.1.148
Rapp, 1994, Memory systems on normal and pathological aging, Curr. Opin. Neurol., 7, 294, 10.1097/00019052-199408000-00003
Rapp, 1993, Neuropsychological analysis of learning and memory in the aged nonhuman primate, Neurobiol. Aging, 14, 627, 10.1016/0197-4580(93)90050-L
Arnsten, 1993, Postsynaptic alpha-2 receptor stimulation improves memory in aged monkeys: Indirect effects of yohimbine versus direct effects of clonidine, Neurobiol. Aging, 14, 597, 10.1016/0197-4580(93)90044-C
Flicker, 1987, A visual recognition memory test for the assesment of cognitive function in aging and dementia, Exp. Aging Res., 13, 127, 10.1080/03610738708259313
Flicker, 1985, Cognitive function in normal aging and early dementia, 1
Mace, 1991
Albert, 1997, The ageing brain: Normal and abnormal memory, Phil. Trans. R. Soc. London, 352, 1703, 10.1098/rstb.1997.0152
Luszcz, 1999, Toward understanding age-related memory loss in late adulthood, Gerontology, 45, 2, 10.1159/000022048
Crook, 1993, Diagnosis and treatment of memory loss in older patients who are not demented, 95
1994
Alhainon, 1993, Psychometric discrimination of tetrahydroaminoacridine responders in Alzheimer patients, Dementia, 4, 54
Lawrence, 1995, Alzheimer's disease, attention, and the cholinergic system, Alzheimer Dis. Assoc. Disord., 9, 43, 10.1097/00002093-199501002-00008
Voytko, 1994, Basal forebrain lesions in monkeys disrupt attention but not learning and memory, J. Neurosci., 14, 167, 10.1523/JNEUROSCI.14-01-00167.1994
Gallagher, 1995, Aging: The cholinergic hypothesis of cognitive decline, Curr. Opin. Neurobiol., 5, 161, 10.1016/0959-4388(95)80022-0
Voytko, 1996, Cognitive functions of the basal forebrain cholinergic system in monkeys: memory or attention?, Behav. Brain Res., 75, 13, 10.1016/0166-4328(95)00143-3
Baxter, 1997, Cognitive effects of selective loss of basal forebrain cholinergic neurons—Implications for cholinergic therapies of Alzheimer's disease
Baxter, 1998, Cognitive functions of the basal forebrain, Curr. Opin. Neurobiol.
Bartus, 1979, Recent memory in aged nonhuman primates: Hypersensensitivity to visual interference during retention, Exp. Aging, 5, 385, 10.1080/03610737908257214
Chiba, 1998, Selective removal of cholinergic neurons in the basal forebrain alters cued target detection in rats, NeuroReport
Solomon, 1988, Age-related disruption of classical conditioning: A model systems approach to memory disorders, Neurobiol. Aging, 9, 535, 10.1016/S0197-4580(88)80110-6
Gallagher, 1988, Spatial learning deficits in old rats: A model for memory decline in the aged, Neurobiol. Aging, 9, 548, 10.1016/S0197-4580(88)80112-X
Kesner, 1988, Reevaluation of the contribution of the basla forebrain cholinergic system to memory, Neurobiol. Aging, 9, 609, 10.1016/S0197-4580(88)80122-2
Barnes, 1988, Aging and the physiology of spatial learning, Neurobiol. Aging, 9, 563, 10.1016/S0197-4580(88)80114-3
Landfield, 1988, Hippocampal neurobiological mechanisms of age-related memory dysfunction, Neurobiol. Aging, 9, 571, 10.1016/S0197-4580(88)80116-7
Dean, 1981, Age-related differences in behavior across the life span of the C57BL/6J mouse, Exp. Aging Res., 7, 427, 10.1080/03610738108259823
Bartus, 1980, Cholinergic drug effects on memory and cognition in animals
Semple, 1982, The Alzheimer's disease syndrome, 93
John, E, 1967, Mechanisms of Memory, Academic Press, New York, NY.
Buchel, 1999, The predictive value of changes in effective connectivity for human learning, Science, 283, 1538, 10.1126/science.283.5407.1538
Jarrard, 1971, Short-term memory in the monkey, 1
Medin, D, and, R. Davis, 1974, Memory. In, Behavior of Nonhuman Primates: Modern Research Trends, (, S. A and F. Stollnitz, Eds.), Academic Press, New York.
Fletcher, H., and J. Davis. 1965. The delayed response problem. Behavior of Nonhuman Primates (A. M. Schrier, Ed.), pp. 129–165. Academic Press, New York.
Barnes, 1983, Loss of place specificity in hippocampal complex spike cells of the senescent rat, Neurobiol. Aging, 4, 113, 10.1016/0197-4580(83)90034-9
Shen, 1996, Differential effects of selective immunotoxic lesions of medial septal cholinergic cells on spatial working and reference memory, Behav. Neurosci., 110, 1181, 10.1037/0735-7044.110.5.1181
Bartus, 1985, Selective memory loss following nucleus basalis lesions: Long term behavioral recovery despite persistent cholinergic deficiencies, Pharmacol. Biochem. Behav., 23, 125, 10.1016/0091-3057(85)90139-X
Kesner, 1997, Structure and dynamics of multiple memory systems in Alzheimer's disease, 3
Gold, P., and J. McGauch. 1975. Changes in learning and memory during aging. In Advances in Behavioral Biology (J. Ordy, Ed.), pp. 145–148. Plenum, New York.
Kubanis, 1981, Age-related memory deficits in Swiss mice, Behav. Neur. Biol., 32, 241, 10.1016/S0163-1047(81)90555-0
Bartus, 1982, The one-trial passive avoidance procedure as a possible marker of aging, 67
Dean, 1988, Behavioral models of aging in nonhuman primates, Handb. Psychopharmacol., 20, 325, 10.1007/978-1-4613-0933-8_8
Bartus, R., T. Crook, and R. Dean. 1987. Current progress in treating age-related memory problems: A perspective from animal preclinical and human clinical research. In Geriatric Clinical Pharmacology (G. Wood and R. Strong, Eds.), pp. 71–94. Raven Press, New York.
Bartus, 1982, Neuropeptide effects on memory in aged monkeys, Neurobiol. Aging, 3, 61, 10.1016/0197-4580(82)90062-8
Bartus, R., and R. Dean. 1988. Effects of cholinergic and adrenergic enhancing drugs on memory in aged monkeys. In Current Research in Alzheimer Therapy (E. Giacobini and R. Becker, Eds.), pp. 179–190. Taylor and Francis, New York.
Bartus, 1988, Lack of effect of clonidine on memory test in aged Cebus monkeys, Neurobiol. Aging, 9, 409, 10.1016/S0197-4580(88)80089-7
Arnsten, 1985, Alpha-2-adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates, Science, 230, 1273, 10.1126/science.2999977
Arnsten, 1995, Dopamine D2 receptor mechanisms contribute to age-related cognitive decline: The effects of quinpirole on memory and motor performance in monkeys, J. Neurosci., 15, 3429, 10.1523/JNEUROSCI.15-05-03429.1995
Coull, 1994, Pharmacological manipulations of the alpha 2-noradrenergic system. Effects on cognition, Drugs Aging, 5, 116, 10.2165/00002512-199405020-00005
Schlegel, 1989, Guanfacine treatment of Alzheimer's disease, Clin. Neuropharmacol., 12, 124, 10.1097/00002826-198904000-00007
Crook, 1992, Noradrenergic Intervention in Alzheimer's Disease, Psychopharmacol. Bull., 28, 67
McEntee, 1991, Treatment of adult-onset cognitive disorders: results of multicenter trials, Psychopharmacol. Bull., 27, 41
Mohr, 1989, Clonidine treatment in Alzheimer's disease, Arch. Neurol., 46, 376, 10.1001/archneur.1989.00520400030015
Bierer, 1994, A pilot study of clonidine plus physostigmine in Alzheimer's disease, Dementia, 5, 243
Haroutunian, 1990, Restoration of cholinomimetic activity by clonidine in cholinergic plus noradrenergic lesioned rats, Brain Res., 507, 261, 10.1016/0006-8993(90)90280-O
Haroutunian, V., A. Santucci, and K. Davis. 1997. Neurotransmitter interactions and responsivity to cholinomimetic agents. In Neurotransmitter Interactions and Cognitive Function (E. Levin, M. Decker, and L. Butcher, Eds.), pp. 119–143. Birkhauser, Boston.
Bartus, 1976, Short-term memory in the Rhesus monkey: Disruption from the anticholinergic scopolamine, Pharmacol. Biochem. Behav., 5, 39, 10.1016/0091-3057(76)90286-0
McDonald, 1998, Present imperfect: A critical review of animal models of the mnemonic impairments in Alzheimer's disease, Neurosci. Biobehav. Rev., 22, 99, 10.1016/S0149-7634(97)00024-9
Penetar, 1983, Effect of cholinergic drugs on delayed match-to-sample performance of rhesus monkeys, Pharacol. Biochem. Behav., 19
Bartus, 1979, Evidence for a direct cholinergic imvolvement in the scopolamine-induced amnesia in monkeys: Effects of concurrent administration of physostigmine and methylphenidate with scopolamine, Pharmacol. Biochem. Behav., 9, 833, 10.1016/0091-3057(78)90364-7
Bartus, 1978, Short-term memory in the Rhesus monkey: Effects of dopamine blockade via acute haloperidol administration, Pharmacol. Biochem. Behav., 9, 353, 10.1016/0091-3057(78)90296-4
Dean, 1982, Drug induced memory impairments in nonhuman primates, Soc. Neurosci. Abstr., 8, 322
Askew, 1974, Effect of tetrahydrocannabinols on brain acetylcholine, Brain Res., 69, 375, 10.1016/0006-8993(74)90018-3
Domino, 1981, Cannabinoids and the cholinergic system, J. Clin. Pharmacol., 21, 249s, 10.1002/j.1552-4604.1981.tb02602.x
Ladinsky, 1981, Interaction of benzodiazepines with known and putative neurotransmitters in the brain
Clemmesen, 1984, Assessments of the anticholinergic effects of antidepressants in a single-dose cross over study of salivation and plasma levels, Psychopharmacology, 82, 348, 10.1007/BF00427684
Palmer, 1993, Monoamine neurons in Alzheimer's disease, Neural Transm. Gen. Sect., 91, 135, 10.1007/BF01245229
Ogura, 1993, MK-801 impairs recogition memory in rhesus mondeys: comparison with cholinergic drugs, Pharmacol. Exp. Ther., 266, 60
Matsuoka, 1996, Cholinergic-glutamatergic interactions in visual recognition memory of rhesus monkeys, Neuroreport, 7, 565, 10.1097/00001756-199601310-00045
Aigner, 1995, Pharmacology of memory: cholinergic-glutamatergic interactions, Curr. Opin. Neurobiol., 5, 155, 10.1016/0959-4388(95)80021-2
Herz, 1960, Die Gedentung der Gahung fur die wirkung von scopolamin und ahnlichen, Z. Biol., 112, 104
Meyers, 1964, The effect of cholinergic blocking drugs on spontaneous alteration in rats, Arch. Int. Pharmacodyn., 150, 3
Meyers, 1964, Some effects of muscarinc cholinergic blocking drugs on behavior and the electrocorticogram, Psychopharmacology, 5, 289, 10.1007/BF02341261
Deutsch, 1966, Anticholinesterase-induced amnesia and its temporal aspects, Science, 151, 221, 10.1126/science.151.3707.221
Deutsch, 1971, The cholinergic synapse and the site of memory, Science, 174, 788, 10.1126/science.174.4011.788
Kubanis, 1981, Age-related behavioral and neurobiological changes: A review with an emphasis on memory, Behav. Neural. Biol., 31, 115, 10.1016/S0163-1047(81)91195-X
Rigter, 1979, Modulation of memory by pituitary hormones and related peptides, Vitam Horm, 37, 153, 10.1016/S0083-6729(08)61070-5
Beatty, 1986, Patterns of memory failure after scopolamine treatment: Implications for cholinergic hypotheses of dementia, Behav. Neural. Biol., 45, 196, 10.1016/S0163-1047(86)90772-7
Molchan, 1992, Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model, Brain Res. Rev., 17, 215, 10.1016/0165-0173(92)90017-G
Newhouse, 1990, Cholinergic studies in dementia and depression, 65
Aigner, 1987, Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic-acid lesions of the nucleus basalis of Meynert, Psychopharmacology, 92, 292, 10.1007/BF00210833
Flicker, 1983, Behavioral and neurochemical effects following neurotoxic lesions of a major cholinergic input to the cerebral cortex in the rat, Pharmacol. Biochem. Behav., 18, 973, 10.1016/S0091-3057(83)80023-9
Dunnett, 1987, Behavioal, biochemical, and histochemical effects of different neurotoxic amino acids injected into nucleus basalis magnocellularis of rats, Neuroscience, 20, 653, 10.1016/0306-4522(87)90117-5
Dunnett, 1991, The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions, Trends Neurosci., 14, 494, 10.1016/0166-2236(91)90061-X
Wenk, 1992, Basal forebrain neurons and memory: A biochemical, histological, and behavioral study of differential vulnerability to ibotenate quisqualate, Behav. Neurosci., 106, 909, 10.1037/0735-7044.106.6.909
Wenk, 1994, Behavioral, biochemical, histological, and electrophysiological effects of 192 IgG-saporin injections into the basal forebrain of rats, J. Neurosci., 14, 5986, 10.1523/JNEUROSCI.14-10-05986.1994
Lashley, 1929
Bartus, 1986, Behavioral recovery following bilateral lesions of the nucleus basalis does not occur spontaneously, Pharmacol. Biochem. Behav., 24, 1287, 10.1016/0091-3057(86)90186-3
Chappell, 1998, A re-examination of the role of basal forebrain cholinergic neurons in spatial working memory, Neuropharmacology, 37, 481, 10.1016/S0028-3908(98)00032-X
Berger-Sweeney, 1994, Differential effects on spatial navigation of immunotoxin-induced cholinergic lesions of the medial septal area and nucleus basalis magnocellularis, J. Neurosci., 14, 4507, 10.1523/JNEUROSCI.14-07-04507.1994
Mishkin, 1978, Memory in monkeys severely impaired by combined but not by separate removal of amygdala and hippocampus, Nature, 273, 297, 10.1038/273297a0
Mishkin, 1993, Neural circuitry underlying behavioral deficits in aging, Neurobiol. Aging, 14, 615, 10.1016/0197-4580(93)90047-F
Fine, 1997, Learning impairment following injection of a selective cholinergic immunotoxin, ME20.4 IgG-saporin, into the basal nucleus of Meynert in monkeys, Neuroscience, 81, 331, 10.1016/S0306-4522(97)00208-X
Ridley, 1998, Different effects on learning ability following injection of the cholinergic immunotoxin ME20.4gC-saporin into the diagonal band of Broca, basal nucleus of Meynert, or both in monkeys, Behav. Neurosci.
Irle, 1987, Basal forebrain-lesioned monkeys are severely impaired in tasks of association and recognition memory, Ann. Neurol., 22, 735, 10.1002/ana.410220610
Gritti, 1997, GABAergic and other noncholinergic basa forebrain neurons, together with cholinergic neurons, project to the mesocortex and iscortex in the rat, J. Compar. Neurol., 383, 163, 10.1002/(SICI)1096-9861(19970630)383:2<163::AID-CNE4>3.0.CO;2-Z
Sparks, 1992, Monoaminergic and cholinergic snyaptic markers in the nucleus basalis of Meynert (nbM): Normal age-related changes and the effect of heart disease and Alzheimer disease, Ann. Neurol., 31, 611, 10.1002/ana.410310608
Backman, 1996, Systemic administration of a nerve growth factor conjugate reverses age-related cognitive dysfunction and prevents cholinergic neuron atrophy, J. Neurosci., 16, 5437, 10.1523/JNEUROSCI.16-17-05437.1996
Fischer, 1992, Progressive decline in spatial learning and integrity of forebrain cholinergic neurons during aging, Neurobiol. Aging, 13, 2, 10.1016/0197-4580(92)90003-G
Fischer, 1994, Reversal of spatial memory impairments in aged rats by nerve growth factor and neurotrophins 3 and 4/5 but not by brain-derived neurotrophic factor, Proc. Natl. Acad. Sci. USA, 91, 8607, 10.1073/pnas.91.18.8607
Serrano-Martinez, 1996, Long-term functional recovery from age-induced spatial memory impairments by nerve growth factor gene transfer to the rat basal forebrain, Proc. Natl. Acad. Sci. USA, 93, 6355, 10.1073/pnas.93.13.6355
Chen, 1997, Disruption of a single allele of the nerve growth factor gene results in atrophy of basal forebrain cholinergic neurons and memory deficits, J. Neurosci., 17, 7288, 10.1523/JNEUROSCI.17-19-07288.1997
Selkoe, 1989, Molecular pathology of amyloidgenic proteins and the role of vascular amyloidosis in Alzheimer's disease, Neurobiol. Aging, 10, 387, 10.1016/0197-4580(89)90072-9
Auld, 1998, Beta-amyloid peptides as direct cholinergic neuromodulators: A missing link?, Trends Neurosci., 43, 10.1016/S0166-2236(97)01144-2
Moran, 1995, Age related learning deficits in transgenic mice expressing the 751-amino acid sioform of human B-amyloid precursor protein, Proc. Natl. Acad. Sci. USA, 92, 5341, 10.1073/pnas.92.12.5341
McKee, 1998, The neurotoxicity of amyloid beta protein in aged primates, Amyloid, 5, 1, 10.3109/13506129809007283
Alvarez, 1997, Acetylcholinesterase promotes the aggregation of amyloid-B-peptide fragments by forming a complex with the growing fibrils, J. Mol. Biol., 272, 348, 10.1006/jmbi.1997.1245
Alvarez, 1998, Stable complexes involving acetylcholinesterase and amyloid-B peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils, J. Neurosci., 18, 3213, 10.1523/JNEUROSCI.18-09-03213.1998
Reyes, 1997, A monoclonal antibody against acetylcholinesterase inhibits the formation of anmyloid fibrils induced by the enzyme, Biochem. Biophys. Res. Commun., 232, 652, 10.1006/bbrc.1997.6357
Loring, 1996, Rational design of an animal model for Alzheimer's disease: Introduction of multiple human genomic transgenes to reproduce AD pathology in rodent, Neurobiol. Aging, 17, 173, 10.1016/0197-4580(95)02076-4
Rogers, 1998, A 24-week double-blind placebo-controlled trial of donepezil in patients with AD, Neurology, 50, 136, 10.1212/WNL.50.1.136
Bartus, 1990, Drugs to treat age-related neurodegenerative problems: The final frontier of medical science?, J. Am. Geriatr. Soc., 38, 680, 10.1111/j.1532-5415.1990.tb01430.x
Sahakian, 1989, The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type, Br. J. Psychiatry, 154, 797, 10.1192/bjp.154.6.797
Nordberg, 1998, Long-term tacrine treatment in three mild Alzheimer patients: Effects on nicotinic receptors, cerebral blood flow, glucose metabolism, EEG, and cognitive abilities, Alzheimer Dis. Assoc. Disord., 12, 228, 10.1097/00002093-199809000-00017
Jones, 1992, Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease, Psychopharmacology (Berl), 108, 485, 10.1007/BF02247426
Nordberg, 1986, Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains, Neurosci. Lett., 72, 115, 10.1016/0304-3940(86)90629-4
Flynn, 1986, Characterization of L-[3H]nicotine binding in human cerebral cortex: Comparison between Alzheimer's disease and the normal, J. Neurochem., 47, 1948, 10.1111/j.1471-4159.1986.tb13113.x
Pery, 1995, Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia, Alzheimer's disease: Possible index of early neuropathology, Neuroscience, 64, 385, 10.1016/0306-4522(94)00410-7
Marutle, 1999, Neuronal nicotinic recpetor deficits in Alzheimer patients with the Swedish amyloid precursor protein 670–671 mutation, J. Neurochem., 72, 1161, 10.1046/j.1471-4159.2000.0721161.x
Whitehouse, 1986, Nicotinic acetylcholine binding sites in Alzheimer's disease, Brain Res., 371, 146, 10.1016/0006-8993(86)90819-X
Whitehouse, 1988, Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: An autoradiographic study, Neurology, 38, 720, 10.1212/WNL.38.5.720
Prendergrast, 1997, Improvement in accuracy of depayed recall in aged and non-aged, mature monkeys after intramuscular or transdermal administration of the CNS nicotinic receptor agonist ABT-418, Psychopharmacology, 130, 276, 10.1007/s002130050240
Jorm, 1986, Effects of cholinergic enhancement therapies on memory function in Alzheimer's disease: A meta-analysis of the literature, Australian N. Z. J. Psychiatry, 20, 237, 10.3109/00048678609161337
Eagger, 1995, Clinical heterogeneity: responders to cholinergic therapy, Alzheimer Dis. Assoc. Disord., 9, 37, 10.1097/00002093-199501002-00007
Alhainen, 1993, Discrimination of Alzheimer's patients responding to cholinesterase inhibitor therapy, Acta. Neurol. Scand., Suppl 149, 16
Farlow, 1996, Apolipoprotein E genotype and gender influence response to tacrine therapy, Ann. NY Acad. Sci., 802, 101, 10.1111/j.1749-6632.1996.tb32603.x
Grothe, 1998, Penetration of tacrine into cerebrospinal fluid in patients with Alzheimer's disease, J. Clin. Psychopharmacol., 18, 78, 10.1097/00004714-199802000-00013
Lou, 1996, Bioavailability and pharmacokinetic disposition of tacrine in elderly patients with Alzheimer's disease, J. Psychiatry Neurosci., 21, 334
Flicker, 1999, Acetylocholinesterase inhibitors for Alzheimer's disease, Br. Med. J., 318, 615, 10.1136/bmj.318.7184.615
Stern, 1987, Effects of oral physostigmine in Alzheimer's disease, Ann. Neurol., 22, 306, 10.1002/ana.410220305
Mayeux, 1999, Treatment of Alzheimer's disease, N. Engl. J. Med., 341, 1670, 10.1056/NEJM199911253412207
Bartus, 1986, Drugs to treat age-related cognitive disorders: on the threshold of a new era in the pharmaceutical industry?
Schumock, 1998, Economic considerations in the treatment and management of Alzheimer's disease, Am. J. Health Syst. Pharm., 55, S17, 10.1093/ajhp/55.suppl_2.S17
Schneider, 1994, Emerging drugs for Alzheimer's disease: Mechanisms of action and prospects for cognitive enhancing medications, Med. Clin. North Am., 78, 911, 10.1016/S0025-7125(16)30142-0
Somerset, P, 1997, Somerset Pharmaceuticals reports results of clinical trial in Alzheimer's disease, PR Newswire, November 3, 1997.
Rosler, 1999, Efficacy and safety of rivastigmine in patients with Alzheimer's disease: International randomised controlled trial, British Medical Journal, 318, 633, 10.1136/bmj.318.7184.633
Giacobini, 1994, Therapy for Alzheimer's disease. Symptomatic or neuroprotective?, Mol. Neurobiol., 9, 115, 10.1007/BF02816110
Crowley, 1999, Big study hopes to find if Alzheimer's can be prevented in memory-impaired, Wall Street Journal.
van Duijn, 1991, Relation between nicotine intake and Alzheimer's disease, Br. Med. J., 302, 1491, 10.1136/bmj.302.6791.1491
Cohen, 1975, Brain acetylcholine: Increases after systemic choline administration, Life Sci., 16, 1095, 10.1016/0024-3205(75)90194-0
Bartus, 1984, Cholinergic precursor therapy for geriatric cognition: It's past, present, and a question of its future, 191
Bartus, R. T., R. L. Dean, K. S. Sherman, E. Friedman, and B. Beer. 1981. Profound effects of combining choline and piracetam on memory enhancement and cholinergic functions in aged rats. 2: 105–111.
Bartus, 1980, Age-related changes in passive avoidance retention and modulation with chronic dietary choline, Science, 209, 301, 10.1126/science.7384805
Schwarz, 1997, Muscarinic receptor agonists under development for the treatment of Alzheimer's disease, Alzheimer's Dis. ID Res. Alert, 2, 5459
Pang, 1998, Alzheimer's Disease, AAPS News, 1, 11
Yaffe, 1998, Estrogen therapy in post-menopausal women: effects on cognitive function and dementia, JAMA, 279, 688, 10.1001/jama.279.9.688
Henderson, 1994, Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects, Arch. Neurol., 51, 896, 10.1001/archneur.1994.00540210068014
Gibbs, 1994, Estrogen and nerve growth factor-related systems in brain. Effects on basal forebrain cholinergic neurons and implications for learning and memory processes and aging, Ann. NY Acad. Sci., 743, 165, 10.1111/j.1749-6632.1994.tb55792.x
Hefti, 1989, Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases, Neurobiol. Aging, 10, 515, 10.1016/0197-4580(89)90118-8
Ingvar, 1997, Enhancement by an ampakine of memory encoding in humans, Exp. Neurol., 146, 553, 10.1006/exnr.1997.6581
Kim, 1997, Enhanced release of secreted form of Alzheimer's amyloid precursor protein from PC12 cells by nicotine, Mol. Pharmacol., 52, 430, 10.1124/mol.52.3.430